These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6548907)

  • 21. Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it?
    Juncal VR; Abdo Jorge F; Paranhos A; Santos Prata T
    Can J Ophthalmol; 2015 Aug; 50(4):297-301. PubMed ID: 26257224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical carbonic anhydrase inhibitors: potential adjuvants to glaucoma therapy in the future.
    Scott BT
    Optom Vis Sci; 1994 May; 71(5):332-8. PubMed ID: 8065709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors with strong topical antiglaucoma properties incorporating a 4-(2-aminopyrimidin-4-yl-amino)-benzenesulfonamide scaffold.
    Casini A; Mincione F; Vullo D; Menabuoni L; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2002 Feb; 17(1):9-18. PubMed ID: 12365464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of topical carbonic anhydrase inhibitors: ocular hypotensive effect of thiadiazole derivatives.
    Chiang CH; Lee AR; Lin CH
    J Ocul Pharmacol; 1993; 9(2):109-15. PubMed ID: 8345284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability studies of topical carbonic anhydrase inhibitor 6-hydroxyethoxy-2-benzothiazole sulfonamide.
    Chiang CH; Hsieh CH; Lu DW; Kao KD
    J Pharm Sci; 1992 Mar; 81(3):299-302. PubMed ID: 1640372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
    Sugrue MF
    J Ocul Pharmacol Ther; 1996; 12(3):363-76. PubMed ID: 8875343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular distribution studies of the topical carbonic anhydrase inhibitors L-643,799 and L-650,719 and related alkyl prodrugs.
    Grove J; Gautheron P; Plazonnet B; Sugrue MF
    J Ocul Pharmacol; 1988; 4(4):279-90. PubMed ID: 3246565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
    Viestenz A; Martus P; Schlötzer-Schrehardt U; Langenbucher A; Mardin CY
    Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of arylamine acetyltransferase in the rabbit eye.
    Campbell DA; Schoenwald RD; Duffel MW; Barfknecht CF
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2190-200. PubMed ID: 2071333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trusopt, a topical carbonic anhydrase inhibitor.
    Donohue EK; Wilensky JT
    J Glaucoma; 1996 Feb; 5(1):68-74. PubMed ID: 8795737
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mode of action, clinical profile and relevance of carbonic anhydrase inhibitors in glaucoma therapy].
    Eichhorn M
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):146-9. PubMed ID: 23430679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit.
    Fanous MM; Challa P; Maren TH
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):51-7. PubMed ID: 10048347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits.
    Loftsson T; Frithriksdóttir H; Stefánsson E; Thórisdóttir S; Guthmundsson O; Sigthórsson T
    J Pharm Pharmacol; 1994 Jun; 46(6):503-4. PubMed ID: 7932047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of carbonic anhydrase in lens ion transport and metabolism.
    Friedland BR; Maren TH
    Ann N Y Acad Sci; 1984; 429():582-6. PubMed ID: 6430196
    [No Abstract]   [Full Text] [Related]  

  • 35. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
    Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
    Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraocular pressure lowering effects of novel arylpiperazine derivatives.
    Chiang CH; Chang TJ; Lu DW; Lee AR
    J Ocul Pharmacol Ther; 1998 Aug; 14(4):313-22. PubMed ID: 9715434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient tolerance to carbonic anhydrase inhibitors.
    Lichter PR; Newman LP; Wheeler NC; Beall OV
    Am J Ophthalmol; 1978 Apr; 85(4):495-502. PubMed ID: 655230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors.
    Brechue WF; Maren TH
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2581-7. PubMed ID: 8325759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma.
    Giuffrida S; Bucolo C; Drago F
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):527-34. PubMed ID: 14733710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial.
    Plager DA; Whitson JT; Netland PA; Vijaya L; Sathyan P; Sood D; Krishnadas SR; Robin AL; Gross RD; Scheib SA; Scott H; Dickerson JE;
    J AAPOS; 2009 Aug; 13(4):384-90. PubMed ID: 19683191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.